IL216148A0 - Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide - Google Patents
Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramideInfo
- Publication number
- IL216148A0 IL216148A0 IL216148A IL21614811A IL216148A0 IL 216148 A0 IL216148 A0 IL 216148A0 IL 216148 A IL216148 A IL 216148A IL 21614811 A IL21614811 A IL 21614811A IL 216148 A0 IL216148 A0 IL 216148A0
- Authority
- IL
- Israel
- Prior art keywords
- dimethyl
- butyramide
- morpholin
- phenyl
- stable forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200900597 | 2009-05-11 | ||
PCT/DK2010/050101 WO2010130260A2 (en) | 2009-05-11 | 2010-05-11 | Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide |
Publications (1)
Publication Number | Publication Date |
---|---|
IL216148A0 true IL216148A0 (en) | 2012-01-31 |
Family
ID=42237259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL216148A IL216148A0 (en) | 2009-05-11 | 2011-11-03 | Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP2430008A2 (en) |
JP (1) | JP2012526152A (en) |
KR (1) | KR20120022934A (en) |
CN (1) | CN102459208A (en) |
AR (1) | AR076556A1 (en) |
AU (1) | AU2010246724B2 (en) |
BR (1) | BRPI1013930A2 (en) |
CA (1) | CA2761383A1 (en) |
CL (1) | CL2011002814A1 (en) |
CO (1) | CO6460741A2 (en) |
CR (1) | CR20110590A (en) |
DO (1) | DOP2011000351A (en) |
EA (1) | EA201171381A1 (en) |
GE (1) | GEP20146006B (en) |
IL (1) | IL216148A0 (en) |
MA (1) | MA33351B1 (en) |
MX (1) | MX2011011885A (en) |
NZ (1) | NZ596738A (en) |
SG (1) | SG175968A1 (en) |
TN (1) | TN2011000557A1 (en) |
TW (1) | TW201041857A (en) |
WO (1) | WO2010130260A2 (en) |
ZA (1) | ZA201108112B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI349666B (en) * | 2004-03-12 | 2011-10-01 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivatives |
JP5419691B2 (en) * | 2006-08-23 | 2014-02-19 | バレアント ファーマシューティカルズ インターナショナル | Derivatives of 4- (N-azacycloalkyl) anilide as potassium channel modulators |
JP2011513196A (en) * | 2007-08-01 | 2011-04-28 | ハー・ルンドベック・アクチエゼルスカベット | Use of a KCNQ potassium channel opener to alleviate symptoms of or treat a disorder or condition in which the dopaminergic system is disrupted |
-
2010
- 2010-05-06 TW TW099114459A patent/TW201041857A/en unknown
- 2010-05-10 AR ARP100101588A patent/AR076556A1/en unknown
- 2010-05-11 MX MX2011011885A patent/MX2011011885A/en not_active Application Discontinuation
- 2010-05-11 NZ NZ596738A patent/NZ596738A/en not_active IP Right Cessation
- 2010-05-11 SG SG2011082492A patent/SG175968A1/en unknown
- 2010-05-11 WO PCT/DK2010/050101 patent/WO2010130260A2/en active Application Filing
- 2010-05-11 MA MA34435A patent/MA33351B1/en unknown
- 2010-05-11 EA EA201171381A patent/EA201171381A1/en unknown
- 2010-05-11 KR KR1020117026958A patent/KR20120022934A/en not_active Application Discontinuation
- 2010-05-11 BR BRPI1013930A patent/BRPI1013930A2/en not_active IP Right Cessation
- 2010-05-11 EP EP10719726A patent/EP2430008A2/en not_active Withdrawn
- 2010-05-11 JP JP2012510116A patent/JP2012526152A/en active Pending
- 2010-05-11 AU AU2010246724A patent/AU2010246724B2/en not_active Ceased
- 2010-05-11 CN CN2010800321765A patent/CN102459208A/en active Pending
- 2010-05-11 GE GEAP201012498A patent/GEP20146006B/en unknown
- 2010-05-11 CA CA2761383A patent/CA2761383A1/en not_active Abandoned
-
2011
- 2011-11-03 IL IL216148A patent/IL216148A0/en unknown
- 2011-11-04 TN TNP2011000557A patent/TN2011000557A1/en unknown
- 2011-11-04 ZA ZA2011/08112A patent/ZA201108112B/en unknown
- 2011-11-10 CL CL2011002814A patent/CL2011002814A1/en unknown
- 2011-11-11 CO CO11153611A patent/CO6460741A2/en not_active Application Discontinuation
- 2011-11-11 CR CR20110590A patent/CR20110590A/en unknown
- 2011-11-11 DO DO2011000351A patent/DOP2011000351A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201108112B (en) | 2013-01-30 |
TW201041857A (en) | 2010-12-01 |
BRPI1013930A2 (en) | 2019-09-24 |
MX2011011885A (en) | 2011-12-06 |
CL2011002814A1 (en) | 2012-04-13 |
TN2011000557A1 (en) | 2013-05-24 |
DOP2011000351A (en) | 2012-01-31 |
MA33351B1 (en) | 2012-06-01 |
JP2012526152A (en) | 2012-10-25 |
SG175968A1 (en) | 2011-12-29 |
WO2010130260A3 (en) | 2011-06-16 |
EP2430008A2 (en) | 2012-03-21 |
WO2010130260A9 (en) | 2012-10-18 |
CA2761383A1 (en) | 2010-11-18 |
CR20110590A (en) | 2012-02-22 |
EA201171381A1 (en) | 2012-05-30 |
WO2010130260A2 (en) | 2010-11-18 |
CO6460741A2 (en) | 2012-06-15 |
AR076556A1 (en) | 2011-06-22 |
AU2010246724A1 (en) | 2011-12-08 |
AU2010246724B2 (en) | 2013-03-21 |
CN102459208A (en) | 2012-05-16 |
NZ596738A (en) | 2013-04-26 |
GEP20146006B (en) | 2014-01-10 |
KR20120022934A (en) | 2012-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1199031A1 (en) | Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof 2--5--1,2,4- | |
HK1194071A1 (en) | Certain triazolopyrazines, compositions thereof and methods of use therefor | |
HK1204227A1 (en) | Benzamide derivatives | |
SI2398785T1 (en) | Purification of 1-s2-(2,4-dimethylphenylsulfanyl)phenylc-piperazine | |
GB0914644D0 (en) | Novel agents and uses thereof | |
EP2427995A4 (en) | Proactive authentication | |
GB0917044D0 (en) | Agents, uses and methods | |
GB0917054D0 (en) | Agents, uses and methods | |
IL219437A0 (en) | Substituted benzamide derivatives | |
EP2451302A4 (en) | Hair addition | |
HK1171451A1 (en) | Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof -- | |
EP2470499A4 (en) | Novel colchicine derivatives, methods and uses thereof | |
EP2598170A4 (en) | Drug-ligand conjugates, synthesis thereof, and intermediates thereto | |
EP2351732A4 (en) | Novel compound ramalin, and use thereof | |
EP2281810A4 (en) | Amide compounds, preparation methods and uses thereof | |
IL216462A0 (en) | Nitrile derivatives, compositions comprising the same and uses thereof | |
EP2311472A4 (en) | Cognitive disorder-ameliorating agent | |
IL217928A0 (en) | Amide derivatives, compositions comprising the same and uses thereof | |
IL215153A0 (en) | Amide derivative compounds, compositions comprising the same and uses there of | |
IL230655A0 (en) | N-hetero-ring-substituted amide derivatives, compositions comprising the same and uses thereof | |
ZA201108112B (en) | Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide | |
PL2429334T3 (en) | Baby's dummy clip | |
SI2325412T1 (en) | Clip, preferably of metal | |
AP2012006129A0 (en) | Benzamide derivatives, preparation and use thereof. | |
EP2509457A4 (en) | Garment clip |